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Cancer is quickly becoming one of the leading causes of death worldwide, which increases 
health-care costs, a number estimated to 17 million new cases of cancer every year in 
developing countries according to Globocan, a WHO (World Health Organization). Cancer 
mainly affects poor people, frequently people with more exposure to risk factors, and often 
have no access to affordable care, and a global misperception associates cancer only with 
wealthy nations and relates it to a sedentary life, tobacco, and fatty diets (López-Gómeza et al., 
2013).  
The development of resistance to chemotherapeutic agents is, unfortunately, the common 
complication in the treatment of different types of cancers in the past few decades, then a 
tremendous variety of chemotherapeutic agents have been introduced and most of them have 
various side effects. Therefore to reduce the discomfort and increase the survival rate for 
patients receiving chemotherapy, current efforts toward anticancer drug development and 
research are looking forward to finding drugs with high efficacy and low side effects. Hence, 
bioactive compounds from natural sources are of particular interest.  
Green plants especially plant-derived medicine are worldwide well known for the treatment 
of diseases, either due to drug resistance or side effects of synthetic drugs and are constantly 
been used for their biological activity as principal indigenous health. They have also played an 
important role as a source of effective anticancer agents, and, significantly, 60% of currently 
used anticancer agents are derived from natural sources including plants, marine organisms, 
and microorganisms (Newman et al., 2003). 
 Moreover, in the past few decades, notable changes in the way of using natural medicine 
have been notified to maintain health care also as an alternative therapy despite many 
challenges. Though scientific studies on the application of many traditional medicinal plants 
have been ventured for ensuring their efficacy and non-toxicity, they haven’t yet been 
supported enough. Lengkuas (Alpina galanga) due to its function, is well known in Indonesia 
as one of the plants which can be utilized in the treatment of diseases. Alpina galanga is a plant 
that belongs to the Zingiberaceae family (Kuntorini, 2005).  Lengkuas is one of the plants that 
can be used as a cancer treatment by increasing apoptosis and inhibiting proliferation. In the 
investigation of Zaeoung, S., et al. (2005), it stated that fresh rhizomes of Alpina galanga 
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methanol extract as an antioxidant removes free radicals and has cytotoxic activity against 
MCF7 (breast adenocarcinoma) and LS174T (colon adenocarcinoma) cell (Zaeoung et al., 
2005) 
   Galangal rhizomes contain flavonoids, tannins, terpenoids, and phenylpropanoids 
(Chudiwal et al., 2010).  Previous research highlights that 1’-acetoxy chavicol acetate extract 
compound from Alpinia galanga extract showed strong cytotoxic activity against T47D breast 
cancer, WiDr colon cancer, Hela cervical cancer, and Vero normal cell line with IC50  values 
of 3.14, 7.26, and 12.49 μg/mL, respectively (Da’i et al., 2019). In addition, previous 
investigations showed the greater of the anticancer activity of ACA upon numerous human 
cancer cell line proliferation such as lung carcinoma/ A549 cell, Leukemia/K 562 cell, HeLa 
cell (Rusmalin, 2003). Besides, 1’S-1’-acetoxy chavicol acetate (ACA) isolated from galangal 
plant induced cytotoxicity in various cancer cells, including cervical cancer in combination 
with miR-629 and RSU1 (Chouni & Paul, 2018). However many research and reviews on 
Alpina galanga showed the presence of diverse phenylpropanoid bioactive compounds. Among 
several compounds purified, p-coumaryl diacetate, 1’-acetoxy chavicol acetate, 1’-acetoxy 
eugenol acetate, and trans-p-acetoxy cinnamyl alcohol were found most potent in vitro against 
cancer cell. Based on the previous investigation of nine analogs of 1′S-1′-acetoxy chavicol 
acetate (ACA) were found selective against seven human cancer cell lines and only  ACA, 1′-
acetoxy eugenol acetate (AEA), and 1′-acetoxy-3,5-dimethoxy chavicol acetate (AMCA) 
induced apoptosis and antiproliferative activity of growth of MDA-MB-231 breast cancer cells 
with a half-maximal inhibitory concentration IC50 value of <30.0 µM (su Ki Liew et al., 2017). 
It has been highlighted that the n-hexane and chloroform lengkuas rhizome extract revealed 
that p-coumaryl alcohol γ-O-methyl ether compound has specific cytotoxic activity against 
cancer cell such as  SNU638 (IC50 = 1.62 μg/mL) (Rangan, 2013). Also, the previous study of 
Ling, Zhao & al., (2012)  showed that 4-acetoxy cinnamyl acetate, 1’-acetoxy chavicol acetate 
showed cytotoxic activity on human lung adenocarcinoma cell A549 (IC50 19.35 μmol/L) (Ling 
et al., 2012). 
Human has commonly used microbial bio-catalysis since thousands of years ago for the 
bread making, dairy products, and alcoholic drinks. Scientifically, Louis (1862) put the first 
scientific bases for the microbial transformation applications, when he used a pure culture of 
Bacterium xylinium used to transform alcohol to acetic acid. Subsequently, several microbial 
transformations' experiments have been carried out, which showed that a one-step procedure 
might produce a remarkable product (Alfarra et al., 2012).  
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Biotransformation could be defined as a specific modification of a definite compound to a 
distinct product with structural similarity, by the use of biological catalysts including 
microorganisms like fungi. The biological catalyst can be an enzyme, or a whole, inactivated 
microorganism that contains an enzyme or several enzymes produced in it (Hegazy et al., 
2015). In other words, biotransformation is defined as the enzymatic conversion of natural and 
chemically synthesized product, into a substance having a specifically modified structure. 
Throughout the biotransformation processes, drugs and chemicals are structurally modified by 
various enzymatic systems to form more polar substances, which can be excreted more easily 
than the original compounds. Problems arise when these modifications generate toxic products. 
Traditionally, drug metabolism studies use in vivo experiments in mice, rat or guinea pig, or 
chimeric mouse models with transplanted human hepatocytes. However, these models can 
create ethical dilemmas; and the experiments are expensive and time-consuming. Moreover, 
metabolites are sometimes produced in low amounts, thus hindering their identification. The 
use of the bioconversion process has gained importance over chemical technologies because of 
process controls, manipulations of microorganisms, safety, and reproducibility. While the 
chemical processes generally involve high temperature, high pressure, and in some cases 
organic solvents. Also, microorganisms are capable to produce a great variety of enzymes in a 
short time as a result of its natural characteristic to multiply. It is also possible to obtain and 
cultivate microorganisms that can survive under extreme environments such as low or high 
temperatures and or acidic or alkali conditions. Microbial transformation can make feasible 
reactions that are not likely to be carried out by traditional synthetic procedures. Numerous 
bioconversion processes have employed biocatalysts such as lipases, amylases, cellulases, 
proteases, and xylanses for commercial production of bio-products.  
Previous investigations on biotransformation studies showed that biotransformation of 
perillyl alcohol with Fusarium culmorum conducted to dehydroperillic acid with a yield of 20.4 
%. Perillyl alcohol was found selective to exert cytotoxicity against HepG2 cell line with an 
IC50 value of 409.2 μg/mL and dehydroperillic acid was found to exert cytotoxic activity 
against A549 cell line with an IC50 value of 125 μg/mL (CE et al., 2017). Besides, microbial 
biotransformation of many bioactive compounds such as terpenoids, alkaloids compounds 
(Marć et al., 2018). Biotransformation has recently evolved as an effective technique for the 
production of structurally diverse molecules with a wide range of biological activities. In an 
attempt to search for new potent anticancer agents, various microorganisms were used for the 
transformation of taxanes (Xu, Zhong-mei, Zhi-yong, et al., 2011). Due to the research 
purposes, the microorganisms firstly were chosen exploratively and randomly. secondly, 
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because they were easy to obtain, and they have also successfully carried out biotransformation 
result in previous research due to their easy manipulation, and their high reproducibility. 
Therefore, it is highly expected that this present research can also biotransform compounds in 
the ethyl acetate fraction of A.galanga extract.  
However, Aristantika (2019) in his research stated that the cytotoxic test and 
antiproliferative activity of galangal extract resulted in an IC50 value of 53.735 µg / mL, where 
the value was less potent as an anticancer (Aristantika, 2019). Therefore, to increase the 
anticancer activity and potency, biotransformation methods are likely an alternative way to 
solve this issue.  
Since in the current study, the interest is in the anti-tumor properties of this traditional herb 
especially to ethyl acetate fraction of  A.galanga extract and used a biotransformation process 
to lead to a new metabolite that could increase the IC50 potency which is one of the important 
parameters in anti-cancer studies.  
 
Following references that have been cited above, in one hand this research goal is more 
interested in investigating this study using fungus as a biocatalyst agent to obtain compounds 
with new structures and in the other hands to determine whether the new metabolite induced 
by the biotransformation process has increased the potency of the cytotoxic parameter (IC50) 
of ethyl acetate fraction of A.galanga extract on T47D by evaluating cytotoxic test using the 


















2. Problem of Statement 
Does the new metabolite variant of A.galanga extract produced by fungus biotransformation 




3. Purpose and Benefit of Study 
Based on the background and formulation of the problem above the purposes and benefits 
of the study obtained as follows : 
 
3.1 Purpose of the study 
Investigate whether, after fungus biotransformation, the new variant of A.galanga extract 
compound was produced? And has higher potency to inhibit T47D cell lines? 
 
 
3.2 The benefit of the study 
3.2.1 Provide insights information on the content about fungus biotransformation and 
anticancer activity of A.galanga extract. 
3.2.2 Add scientific data in the field of health that can be the basis for further research. 
3.2.3 Provide reliable information sources about alternative cancer treatments for the 
community. 
 
 
 
 
 
 
 
 
 
 
 
 
